Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contacts: For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 [email protected]
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Frontier Medicines Corporation ("Frontier" or the "Company"), a clinical-stage precision medicine company unlocking to advance transformational therapies, today announced that Chris Varma, Ph.D., Frontier's co-founder,
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical-stage,
Xenon to Showcase Innovations at J.P. Morgan Healthcare Conference
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your
Element Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced that Element CEO and co-founder Molly He will be presenting a corporate update at the 43rd annual J.
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on ...
Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world​, today announced
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here. OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large,
The LZ experiment's first science run sets new constraints on dark matter interactions
Dark Matter experiment is a large research effort involving over 200 scientists and engineers at 40 institutions worldwide.
International Isotopes, Inc. Announces the Amendment of the Acquisition of the AMICI, Inc. Product Line
International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it ...
Autoblog14y
Popsci: If you've got diamonds and xenon, you might soon have a super battery
So, the WSU researchers put some xenon difluoride inside a diamond anvil and cranked the pressure up to a million atmospheres. What happened next was really cool. The molecules of the xenon ...
Nature2mon
Xenon out of its shell
Xenon's discovery concluded an intense period of research on noble gases. Much heavier than neon and krypton, it had not been explicitly predicted, and was sufficiently rare to avoid chance ...
Yahoo Finance1mon
Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Xenon Pharmaceuticals (XENE). Shares have added about 2.4% in that time frame, outperforming the S&P 500. Will the recent positive ...
Nasdaq25d
Xenon Pharmaceuticals participates in a conference call with William Blair
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks ...
Wall Street Journal1mon
Xenon Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
T-Net6d
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, announced new ...
Nasdaq1mon
Xenon Pharmaceuticals Reveals Promising Epilepsy Drug Data
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Xenon Pharmaceuticals has unveiled promising long-term data from its X-TOLE study, showing that its drug ...